Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 110.2 SEK 0.64% Market Closed
Market Cap: 11.1B SEK
Have any thoughts about
Biogaia AB?
Write Note

Biogaia AB
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biogaia AB
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Biogaia AB
STO:BIOG B
Total Current Assets
kr1.9B
CAGR 3-Years
4%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Total Current Assets
kr511.9m
CAGR 3-Years
17%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Total Current Assets
kr2.1B
CAGR 3-Years
-26%
CAGR 5-Years
15%
CAGR 10-Years
23%
Probi AB
STO:PROB
Total Current Assets
kr562.9m
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
17%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Total Current Assets
kr12.6B
CAGR 3-Years
20%
CAGR 5-Years
18%
CAGR 10-Years
21%
BioArctic AB
STO:BIOA B
Total Current Assets
kr1.2B
CAGR 3-Years
5%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
No Stocks Found

Biogaia AB
Glance View

Market Cap
11.1B SEK
Industry
Biotechnology

BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm. The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.

BIOG B Intrinsic Value
112.88 SEK
Undervaluation 2%
Intrinsic Value
Price

See Also

What is Biogaia AB's Total Current Assets?
Total Current Assets
1.9B SEK

Based on the financial report for Dec 31, 2023, Biogaia AB's Total Current Assets amounts to 1.9B SEK.

What is Biogaia AB's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
31%

Over the last year, the Total Current Assets growth was 4%. The average annual Total Current Assets growth rates for Biogaia AB have been 4% over the past three years , 31% over the past five years .

Back to Top